From Name:
From Email:
To Name:
To Email:

Optional Message:


Psychedelics in palliative care

from Scientific American

The FDA has given MDMA, also known as ecstasy or molly, designation as a breakthrough therapy. It is also in phase III of its clinical trials, the last phase before going to market as a prescription. Colloquially, providers refer to psilocybin as magic mushrooms. New research is confirming its potency by showing that cancer patients treated just once with psilocybin experienced treatment benefits present five years later. For those with anxiety in the face of a new illness diagnosis, treatment with psychedelic medicine provided relief from anxiety, allowing patients the capacity to engage with their medical care with more presence and purpose. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063